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Localized cytokine responses to total 
knee arthroplasty and total knee revision 
complications
Nicole Prince1,2, Julia A. Penatzer1,2, Matthew J. Dietz2 and Jonathan W. Boyd2,3*
Abstract 
Background: The study of localized immune-related factors has proven beneficial for a variety of conditions, and one 
area of interest in the field of orthopaedics is the impact of implants and localized infections on immune response. 
Several cytokines have shown increased systemic concentrations (in serum/plasma) in response to implants and 
infection, but tissue-level cytokines have not been investigated as thoroughly.
Methods: This exploratory study investigated tissue-level cytokines in a cohort of patients (N = 17) in response to 
total knee arthroplasty and total knee revision to better understand the immune response to implants and local-
ized infection (e.g., prosthetic joint infection). The overall goal of this study was to provide insight into the localized 
cytokine response of tissues and identify tissue-level markers specific to inflammation caused by implants vs. inflam-
mation caused by infection. Tissues were collected across several anatomical locations and assayed with a panel of 20 
human inflammatory cytokines to understand spatial differences in cytokine levels.
Results: In this study, six cytokines were elevated in implanted joints, as compared to native joints: IL-10, IL-12p70, 
IL-13, IL-17A, IL-4, and TNF-α (p < 0.05). Seven cytokines showed infection-dependent increases in localized tissues: 
IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β (p < 0.05).
Conclusions: This study demonstrated that differences exist in tissue-level cytokines in response to presence of 
implant, and some cytokines were specifically elevated for infection; these responses may be informative of over-
all tissue health. These results highlight the utility of investigating localized cytokine concentrations to offer novel 
insights for total knee arthroplasty and total knee revision procedures, as well as their complications. Ultimately, this 
information could provide additional, quantitative measurements of tissue to aid clinical decision making and patient 
treatment options.
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Background
The inflammatory response of tissues involves a series of 
biological events regulated by a number of immune fac-
tors, and the actions of these immune factors are par-
tially reliant on the cytokines and chemokines produced 
in response to pathogens, foreign bodies, and other 
stimuli [1–3]. These responses are of interest to the field 
of orthopaedics, especially with regard to the immune 
response to implants, infection, and chronic inflam-
mation [4–6]. An elevated immune response has been 
observed following total knee arthroplasty (TKA) pro-
cedures; increased levels of cytokines, particularly inter-
leukin (IL)-1, IL-4, IL-6, IL-10, and tumor necrosis factor 
alpha (TNF-α), have been shown both on a systemic level 
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(i.e., synovial fluid) [7–9]. However, many aspects of this 
response are not well understood. For example, a major-
ity of TKA procedures are successful, but implant-related 
and infection-related complications can negatively affect 
a patient’s quality of life. Properly addressing these issues 
is of high priority to the field of orthopaedics, especially 
considering the increasing demand for joint replacement 
[10]. Many studies have noted the pain, inflammation, 
and dissatisfaction that can occur following these proce-
dures, affecting approximately 20% of patients undergo-
ing TKA [11, 12], but it is not entirely known what role 
cytokines play in this chronic inflammatory response. 
Infections, such as prosthetic joint infection (PJI), are 
another serious complication and are a leading cause of 
total joint failure [13]. PJI is a localized infection sur-
rounding a prosthetic joint and can result following 
implantation, often necessitating surgical intervention 
[14]. PJI is a major concern following TKA/total knee 
revision (TKR) procedures and can be difficult to treat. 
The infections are often persistent and unable to be 
resolved using conventional methods, presenting a chal-
lenge for clinicians [15]. The systemic immune response 
to PJI has been studied extensively, but the localized tis-
sue response is not as well understood. In order to bet-
ter understand the immune response to implants and 
localized infection, this study investigated levels of 20 
inflammatory cytokines in localized tissue surround-
ing the joint. While defining the localized response to 
implants and infection can be difficult [7–9], localized 
cytokine responses have been investigated for other 
pathological conditions. A few studies have character-
ized localized cytokine responses in trauma [16–18] 
and respiratory infection [19], and these studies demon-
strated that the local cytokine environment differs when 
compared to systemically circulating levels. Currie et al. 
[16] showed that differences in cytokine concentrations 
exist in skeletal muscle samples in a spatially-dependent 
manner using an animal model of traumatic injury. Simi-
larly, Hauser et  al. [18] observed differences in levels of 
cytokines at the site of injury compared to systemic levels 
in response to trauma in humans. Other research groups 
have observed spatially-related differences of other 
immune-related factors for stroke [20], and in response 
to allergens [21] in animal models. These studies intro-
duced the concept of using immune markers on a local-
ized level to better understand these conditions.
TKA and TKR procedures trigger inflammatory cas-
cades, initiating cytokine responses and elevating sys-
temic cytokine concentrations; higher levels of cytokines 
have been observed following these surgeries. The eleva-
tion in cytokine levels has been attributed to the trauma 
of surgery as well as the introduction of implants into the 
body [22, 23]. However, this inflammation is sometimes 
prolonged, which can cause major complications for 
patients. The causes of chronic inflammation following 
these procedures are still unknown, and resolution of the 
inflammation is challenging [24]. Therefore, understand-
ing the changes in inflammatory response specific to 
implant-related inflammation is beneficial to improving 
the outcome of these individuals.
Similarly, the localized response to PJI has not been 
characterized to understand the local immune modu-
lation in these cases. Many studies have investigated 
systemically circulating levels of interleukins and 
other cytokines for their roles in infection, and several 
cytokines are used as diagnostics of PJI [25–27]. Sev-
eral studies have specifically focused on the utility of 
measuring IL-6 and IL-8 levels in serum for diagnos-
ing and monitoring PJI, both of which have increased 
specificity over conventional methods; this knowledge 
has greatly benefitted the clinical treatment options for 
PJI [28, 29]. However, PJI remains one of the most seri-
ous complications following revision knee arthroplasty. 
In fact, infection is one of the most common causes for 
revision, being implicated in 20.4% of all revision TKA 
procedures between 2009 and 2013 [30]. While defining 
the systemic response to sepsis and infection has paved 
the way for improved diagnostics [31–33], less is known 
about the environment of localized infections and what 
role cytokines play in determining tissue health.
The present study focused on understanding differ-
ences in localized distributions of cytokines in TKA and 
TKR procedures, with and without presence of infection, 
using PJI as the model for localized infections. The ulti-
mate goal of this study was to characterize the immune 
modulation on a tissue level that occurs in response to 
joint implantation and infection to better understand 
localized tissue health. The information gained could aid 
clinical management of these complications by narrow-
ing down cytokines that are indicative of response to PJI. 
It represents the first known investigation of tissue-level 
cytokines in response to implant-related and infection-
related complications, to our knowledge.
Patients, materials, and methods
Patients
Following Institutional Review Board (IRB) approval (IRB 
Protocol #1709745853) and patient consent, six patients 
undergoing primary total knee arthroplasty (TKA) and 
11 patients undergoing total knee revision (TKR) pro-
cedures participated in the study (8 males, 9 females; 
aged 45–82  years; body max index [BMI] 24.6–43.7). 
Subjects were recruited over a 12-month period. All six 
primary TKA patients were undergoing elective surgery 
for total replacement of the knee joint with a diagnosis of 
osteoarthritis. At the time of this study, this was the first 
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arthroplasty procedure on either knee joint. In the TKR 
group, patients were further characterized into aseptic 
and septic revision procedures. Patients with aseptic revi-
sions (N = 5) were undergoing revisions due to failures of 
the prosthetic joint but did not show presence of infec-
tion. For ease of the reader, samples from these patients 
will be referred to as aseptic TKR tissues. Patients with 
septic revisions (N = 6) met clinical criteria for a PJI diag-
nosis as defined by the Musculoskeletal Infection Society 
(MSIS) criteria [13]. Samples from these patients will be 
referred to as septic TKR tissues. All six patients diag-
nosed with PJI were tissue culture positive: four tested 
culture positive for Staphylococcus epidermidis, one for 
Methicillin-sensitive Staphylococcus aureus (MSSA), 
and one for Enterobacter cloacae. More patient informa-
tion can be found in Table 1. Systemic C-reactive protein 
(CRP) levels in serum are additionally listed as reference.
Collection of tissue samples
All TKA and TKR procedures were performed by a sin-
gle surgeon with standard debridement and washing pro-
tocols. Tissues were collected at a total of four distinct 
anatomical locations, broadly characterized into two tis-
sue layers: four adjacent tissue layer (ATL) samples and 
three radial tissue layer (RTL) samples. The ATL samples 
came from the initial debridement. Tissues from the ATL 
layer were closer to the knee joint (or prosthetic implant). 
Conversely, RTL samples were taken from a tissue layer 
further removed from the joint (or prosthetic implant) 
after the surgeon completed debridement. The difference 
in depth of the RTL tissues and ATL tissues was approxi-
mately 5–10  mm and was dependent on the individual 
patient. Measurements were made from point of origin to 
standardize tissue samples taken between patients. Tis-
sues were taken at four anatomical locations illustrated in 
Fig. 1. Briefly, the solid line circle represents location (1) 
medial femoral condyle (F); the dashed line circle repre-
sents location (2) medial tibial plateau (T); the solid line 
square represents location (3) lateral gutter (LG); and 
the dashed line square represents location (4) posterior 
capsule (PC). Anatomical locations 1–4 were collected 
for the ATL layer, and locations 1–3 were collected for 
the RTL layer. Location 4, PC, could not be taken in the 
RTL layer due to proximity to neurovascular structures. 
Therefore, a total of seven tissue samples were taken for 
each patient.
Sample preparation
Tissues were collected during TKA and TKR procedures 
in the operating room and immediately stored on dry 
ice. Once all tissues had been collected for an individual 
patient, they were washed with 1× cold phosphate-buff-
ered saline (PBS) to remove blood and debris. Tissues 
were grossly dissected using a scalpel to remove scar tis-
sue or cement, then stored at − 80 ºC. When samples had 
been collected for all patients, tissues were thawed on ice 
Table 1 Patient information
Six primary TKA and 11 revision TKR patients were enrolled in the study, creating a heterogenous cohort of males and females varying in age (45–82 years) and 
comorbidities. Primary TKA patients have ID format P#; revision TKR patients have ID format F#. This table lists general patient information including the pathogen 
for which each septic patient tested culture-positive following testing on the day of surgery. Serum CRP values were obtained pre-operatively in the revision setting. 
Cultures were obtained from intraoperative tissue samples
ID Sex TKA/TKR BMI (kg/m2) Diabetic (Y/N) CRP (mg/L) Culture
P1 F TKA 33.8 N N/A Negative
P2 F TKA 39.8 N N/A Negative
P3 F TKA 39.8 N N/A Negative
P4 M TKA 29.7 Y N/A Negative
P5 M TKA 24.6 N N/A Negative
P6 M TKA 27.2 N N/A Negative
F1 F TKR-aseptic 28.2 N 4.3 Negative
F2 F TKR-aseptic 29.8 N 0.2 Negative
F3 F TKR-aseptic 33.9 N  < 1 Negative
F4 M TKR-aseptic 40.4 Y 3.6 Negative
F5 M TKR-aseptic 26.2 N 2.1 Negative
F6 F TKR-septic 43.7 N 28.8 S. epidermidis
F7 F TKR-septic 30.8 Y 161.4 S. epidermidis
F8 F TKR-septic 41.9 N 21.7 E. cloacae
F9 M TKR-septic 36.2 N 33.5 MSSA
F10 M TKR-septic 33.8 Y 3.8 S. epidermidis
F11 M TKR-septic 31.9 N 111.9 S. epidermidis
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and cut into sections approximately 30 mg in size; tissues 
were homogenized by sonication in 500 µL cell lysis solu-
tion (Bio-Rad, Hercules, CA) containing 20 mM phenyl-
methylsulfonyl fluoride (Sigma-Aldrich, St. Louis, MO). 
Protein extraction was performed using methods adapted 
from Hulse et al. [34]. Thawed samples were vortexed for 
1–3 s and centrifuged at 5000×g for 5 min at 4  °C. The 
supernatant was collected and tested for total protein 
content using a Pierce BCA Protein Assay Kit (Thermo 
Scientific, Waltham, MA), according to manufacturer’s 
instructions. Absorbance values for total protein content 
were determined on an Infinite M1000 multimode plate 
reader (Tecan, Raleigh, NC).
Cytokine measurement
To standardize samples for total protein content, tissue 
homogenates were individually diluted to a total protein 
concentration of 900  µg/mL with cell lysis buffer (Bio-
Rad). Cytokine quantification was performed using a 
magnetic bead-based multiplex Inflammation Human 
ProcartaPlex panel assay (Invitrogen, Carlsbad, CA) and 
measured using a Bio-Plex 200 suspension array system 
and Pro II Wash Station (Bio-Rad), according to the man-
ufacturer’s instructions.
Statistical analysis
Data were analyzed using Prism 5 (GraphPad, San Diego, 
CA) and SAS JMP (Cary, NC). Standard curves were gen-
erated for each protein using either a four- (4PL) or five-
parameter logistic (5PL) regression model, depending 
on the individual protein. Cytokine concentrations were 
determined using standard curve interpolation, then cor-
rected by dilution factor to compare tissue homogenates. 
Cytokine concentrations are expressed as picograms of 
cytokine per milliliter of tissue homogenate (pg/mL). 
Samples with fluorescence intensity values below the 
lower limit of quantitation (LLOQ) or above the upper 
limit of quantitation (ULOQ) were omitted from statisti-
cal comparisons. Outliers were identified using the 1.5× 
interquartile range (IQR) rule and omitted from analysis. 
Two-way analysis of variance (ANOVA) with Bonfer-
roni’s post-test was used to determine significant differ-
ences between primary TKA, aseptic TKR, and septic 
TKR tissue samples at each tissue location. Each tissue 
homogenate was tested in duplicate for cytokine concen-
tration. Data are expressed as the mean ± standard error 
of the mean (SEM).
Quadratic discriminant analysis was conducted to 
evaluate the combined capacity of cytokine response to 
predict the state of tissue. Using SAS JMP, all measured 
responses were cast as covariates, and the “group” was 
assigned as a classification category (primary TKA, asep-
tic TKR, septic TKR). The Shrink Covariances option was 
applied to account for the different covariances within 
the categories. Quadratic discriminant analysis is a pre-
dictive modeling tool, and when there are a large number 
of variables compared to observations, as is the case in 
this study, Shrink Covariances is frequently employed to 
improve the stability and reduce prediction variance [35]. 
This analysis included 13 covariates; only those cytokines 
that produced statistically significant two-way ANOVA 
comparisons for either infection-specific or implant-
specific comparisons were included: IL-1α, IL-1β, IL-6, 
IL-8, monocyte chemoattractant protein (MCP)-1, mac-
rophage inflammatory protein (MIP)-1α, MIP-1β, IL-10, 
IL-12p70, IL-13, IL-17A, and TNF-α. Biplot rays are plot-
ted to indicate how each covariate influences the canoni-
cal space, with the direction and magnitude signifying 
the degree of association with the respective group (pri-
mary TKA, aseptic TKR, septic TKR).
Due to the limited sample size, this study was not able 





Fig. 1 Map of approximate tissue collection locations, shown with 
prosthetic implant illustrated. Seven tissue samples were taken 
for each patient; (1) the solid circle represents the medial femoral 
condyle (denoted as F); (2) the dashed circle represents the medial 
tibial plateau (denoted as T); (3) the solid square represents the lateral 
gutter (denoted as LG); (4) the dashed square represents the posterior 
capsule (denoted as PC). Locations 1–4 were taken for the ATL layer, 
and locations 1–3 were taken for the RTL layer; separation between 
ATL (closer to joint) and RTL (further from joint) was approximately 
5–10 mm, depending on individual patient
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Pearson correlations were run between cytokine concen-
trations and age, sex, and BMI for each patient to analyze 
the contribution of these variables. Bonferroni’s correc-
tion was applied to correct for multiple inferences, as 
previously described by Bland et al. [36].
Results
Changes in cytokine concentrations were observed for 
comparisons of primary TKA vs. aseptic TKR vs. septic 
TKR tissues. Overall, cytokine concentrations were gen-
erally elevated in TKR (both septic and aseptic) com-
pared to TKA, and septic TKR exhibited higher cytokine 
levels than aseptic TKR for several cytokines. Seven 
cytokines (IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, 
and MIP-1β) showed increased concentrations in septic 
TKR tissues compared to both aseptic TKR tissues and 
primary TKA tissues (p < 0.05). Six cytokines (IL-10, 
IL-12p70, IL-13, IL-17A, IL-4, and TNF-α) showed dif-
ferences in concentration between primary TKA and 
TKR (both aseptic and septic) (p < 0.05), but these six 
cytokines were not significantly different between aseptic 
TKR and septic TKR. These comparisons are described 
in detail over the following sections. Additional human 
inflammatory cytokines were tested, but they did not 
produce statistically significant comparisons in this 
study: E-Selectin, granulocyte–macrophage colony-stim-
ulating factor (GM-CSF), interferon-alpha (IFN-α), inter-
feron-gamma (IFN-γ), and interferon gamma-induced 
protein 10 (IP-10).
Seven cytokines exhibited infection‑specific elevation 
in localized tissues
Seven cytokines showed an increase in concentration 
that was dependent on the presence of localized infec-
tion: IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and 
MIP-1β (p < 0.05). For these cytokines, primary TKA 
averages were lowest, with an increase in aseptic TKR 
and further increase in septic TKR. For IL-1α, the aver-
age concentration of primary TKA tissues was 1.1 pg/mL, 
and rose to 11.8 pg/mL in aseptic TKR; the concentration 
was elevated to 30.3  pg/mL in septic TKR. Location-
specific differences are marked in Fig.  2, and it is clear 
that most significant comparisons are present within 
locations of the ATL layer. IL-1β showed a similar trend, 
with a mean of 1.7 pg/mL in primary TKA tissues, which 
rose to 5.4 pg/mL in aseptic TKR, and further elevated to 
39.1  pg/mL in septic TKR. For IL-1β, the most marked 
differences between groups came from comparisons of 
locations ATL LG and ATL PC (Fig.  2). IL-6 followed, 
with an average of 8.5  pg/mL in primary TKA, rising 
to 24.2  pg/mL in aseptic TKR, and finally 610.7  pg/mL 
in septic TKR. Location ATL PC showed the most dra-
matic increase in concentration in septic TKR compared 
to other groups (Fig.  2). IL-8 levels were 7.6  pg/mL in 
primary TKA, which increased to 91.1 pg/mL in aseptic 
TKR, and rose to 553.9 pg/mL in septic TKR. Differences 
in IL-8 were significant between at least two groups at all 
locations besides ATL LG and ATL PC at p < 0.05 (note: 
ATL PC for IL-8 not shown due to omission of outli-
ers). For MCP-1, the average of primary TKA tissues was 
113.0 pg/mL, which increased to 258.8 pg/mL for asep-
tic TKR, and further increased to 565.1 pg/mL for septic 
TKR. RTL LG showed the most significant comparisons 
between groups for MCP-1 (Fig. 2, p < 0.05). MIP-1α fol-
lowed the same trend, with an average of 7.8 pg/mL for 
primary TKA, which rose to 27.8 pg/mL in aseptic TKR, 
and was elevated to 81.6 pg/mL in septic TKR. ATL loca-
tions showed the most significant increases in MIP-1α 
between groups (Fig.  2, p < 0.05). For MIP-1β, primary 
TKA tissues showed an average of 21.3 pg/mL and were 
increased to 46.0  pg/mL for aseptic TKR and further 
increased to 123.4 pg/mL in septic TKR. Locations ATL 
T and ATL PC showed the most significant increases 
between groups for MIP-1β (Fig. 2, p < 0.05). As shown in 
Fig. 2, cytokine concentrations in the ATL layer locations 
were generally higher than the RTL layer locations.
Six cytokines exhibited implant‑related elevation (primary 
TKA vs. aseptic/septic TKR)
Six cytokines, IL-10, IL-12p70, IL-13, IL-17A, IL-4, and 
TNF-α, exhibited higher levels in TKR tissues as com-
pared to primary TKA tissues at a minimum of one 
location (p < 0.05). In other words, there were signifi-
cant differences (p < 0.05) between primary TKA and 
aseptic/septic TKR, but there were no significant differ-
ences between aseptic TKR and septic TKR. For IL-10, 
the average value in primary TKA was 0.9 pg/mL, 8.4 pg/
mL in aseptic TKR, and 6.6  pg/mL in septic TKR. All 
locations showed significantly different comparisons to 
aseptic TKR and septic TKR (Fig.  3, p < 0.05). With the 
same general trend, IL-12p70 had an average of 5.7  pg/
mL in primary TKA, 30.7  pg/mL in aseptic TKR, and 
Fig. 2 Seven cytokines showed infection-dependent elevation in localized tissues. Individual tissue locations are shown for all groups. Two-way 
ANOVAs with Bonferroni’s post-test were conducted to test for significant differences between groups at each individual location (p < 0.05). 
Significant differences between groups at a particular location are marked as: * denotes significant difference from primary TKA (N = 6); # denotes 
significant difference from aseptic TKR (N = 5); % denotes significant difference from septic TKR (N = 6); all symbols denote significance at the 
p < 0.05 level
(See figure on next page.)
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20.7  pg/mL in septic TKR. However, IL-12p70 only 
showed one statistically significant comparison (p < 0.05) 
at the ATL PC location between primary TKA and asep-
tic TKR (Fig. 3). For IL-13, the average in primary TKA 
was 1.8  pg/mL, 9.6  pg/mL in aseptic TKR, and 9.9  pg/
mL in septic TKR. Locations ATL F, ATL T, and RTL F 
exhibited significant comparisons between groups (Fig. 3, 
p < 0.05). Following this trend, IL-17A average concen-
trations were 5.3 pg/mL in primary TKA, 16.3 pg/mL in 
aseptic TKR, and 18.9 pg/mL in septic TKR. All locations 
except RTL T showed significant comparisons (Fig.  3, 
p < 0.05). For IL-4, average concentration in primary 
TKA was 6.9 pg/mL, which rose to 19.6 pg/mL in aseptic 
TKR, and further to 24.8 pg/mL in septic TKR. Again, all 
locations except RTL T showed significant comparisons 
(Fig. 3, p < 0.05). Finally, TNF-α followed the same trend, 
with an average concentration of 16.9 pg/mL in primary 
TKA, 71.1 pg/mL in aseptic TKR, and 86.8 pg/mL in sep-
tic TKR. All locations except RTL T showed significant 
comparisons (Fig. 3, p < 0.05).
Quadratic discriminant analysis (QDA) revealed distinct 
cytokine profiles for TKA vs. TKR
The two-way ANOVA comparisons of cytokines between 
different groups revealed seven cytokines that showed 
infection-specific elevation (beyond inflammation caused 
by implants), and six cytokines that showed increases due 
to implants, but not infection (Figs. 2 and 3). To further 
probe the structure of these cytokine profiles between 
groups, quadratic discriminant analysis was conducted. 
These 13 cytokines were included as covariates. The anal-
ysis classified the combined observed responses into pre-
determined groups of primary TKA, aseptic TKR, and 
septic TKR. The group was predicted based on the covar-
iate responses associated with each group, respectively. 
For each group, all seven locations were included for all 
individuals in that group, which means there were 42 
counts for primary TKA (7 tissue locations, 6 patients), 
35 values for aseptic TKR (7 tissue locations, 5 patients), 
and 42 counts for septic TKR (7 tissue locations, 6 
patients). In total, of 119 counts, only 8 were misclassi-
fied, indicating a good prediction ability of the model. All 
8 misclassifications were errors of a prediction of asep-
tic TKR group, when the values were originally from the 
septic TKR group. In other words, these individuals were 
falsely classified as aseptic based on cytokine profiles 
while they were actually septic. Further, there is over-
lap between the 95% confidence intervals for cytokine 
profiles of aseptic TKR and septic TKR patients (Fig. 4), 
which may be responsible for the misclassification.
Effects of age, sex, and BMI on cytokine concentrations
The research presented here did not control for age, sex, 
or BMI due to the limited sample size of this exploratory 
study. To better understand the connections between 
cytokines of interest (IL-1α, IL-1β, IL-6, IL-8, MCP-1, 
MIP-1α, MIP-1β, IFN-γ, IL-10, IL-13, IL-17A, IL-4, and 
TNF-α) and these factors, Pearson correlations were run 
and analyzed for statistical significance. When the Bon-
ferroni’s correction was applied, as described in [36], 
none of the correlations between cytokine levels and age, 
sex, or BMI were significant (p > 0.05), but the correla-
tions are displayed in Table 2 for transparency. Although 
there is an established connection in the literature 
between inflammatory cytokine levels and age, sex, and 
BMI, the lack of significant Pearson correlation p-values 
indicates these were not confounding variables for this 
study [37–39].
Discussion
Inflammation in response to implants and infection fol-
lowing TKA/TKR procedures remains a serious com-
plication and is a high priority for clinicians. However, 
not much is known about the local immune response 
of the tissue surrounding the implant/infection. While 
a variety of cytokines (and other biomarkers) have been 
researched from a systemic view [40, 41], their clini-
cal use is still debated [31–33, 42]. Further, the cytokine 
responses have not been as well characterized on a local-
ized tissue level. The tissue-level cytokine response may 
add further understanding of the localized environment 
and could give insight into tissue health that would aid 
clinicians in the management of these post-surgical com-
plications through surgical debridement. Tissue-level 
cytokines have been measured with respect to spatial 
gradients in traumatic injury [16–18], respiratory infec-
tion [19], stroke [20], and allergic response [21], and 
these studies provided useful information regarding the 
respective immune responses. These have established a 
basis for this study to investigate the localized implant-
related and infection-specific tissue responses.
(See figure on next page.)
Fig. 3 Six cytokines showed implant-related elevation in localized tissues that was not infection-dependent. Individual tissue locations are shown 
for all groups. Two-way ANOVAs with Bonferroni’s post-test were conducted to test for significant differences between groups at each individual 
location (p < 0.05). Significant differences between groups at a particular location are marked as: * denotes significant difference from primary 
TKA (N = 6); # denotes significant difference from aseptic TKR (N = 5); % denotes significant difference from septic TKR (N = 6); all symbols denote 
significance at the p < 0.05 level
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This study focused on defining the tissue-level cytokine 
environment and modulation in response to implants 
and infection across several anatomical locations. Many 
human inflammatory cytokines have been implicated in 
the systemic response to implants (i.e., in serum/plasma) 
[43–45] and now aid in diagnosis of infection [46, 47]. 
However, this investigation is the first, to our knowl-
edge, to assess multiple tissue locations surrounding the 
joint to address implant-related vs. infection-specific 
responses. Seven cytokines were identified as infection-
specific, showing elevated concentrations in the sep-
tic TKR cohort compared to both the aseptic TKR and 
primary TKA cohorts: IL-1α, IL-1β, IL-6, IL-8, MCP-1, 
MIP-1α, and MIP-1β (p < 0.05). Several of these cytokines 
have illustrated their utility in the literature for diagno-
sis of PJI (i.e. IL-1α, IL-1β, IL-6, IL-8), but this is the first 
instance of their investigation on a tissue level [30–33]. 
Generally, these seven cytokines were elevated in ATL 
layer tissues compared to RTL layer tissues, which brings 
to light the importance of proximity to joint in dictat-
ing cytokine response. Pro-inflammatory cytokines like 
IL-1α, IL-1β, IL-6, and IL-8 have been noted for their 
roles in early infection response, producing a warn-
ing signal of pathogen invasion, and this response 
was present in septic TKR tissues [48, 49]. These early 
cytokine indicators recruit factors like MCP-1, MIP-1α, 
and MIP-1β that propagate the response to pathogens 
through Th1 and Th2 immune signaling cascades [50, 
51]. Six cytokines were identified as exhibiting a response 
due to implantation, with elevations in aseptic and septic 
TKR vs. primary TKA: IL-10, IL-12p70, IL-13, IL-17A, 
IL-4, and TNF-α (p < 0.05). The elevated concentrations 
of these cytokines in localized tissues highlighted the 
degree of inflammation in implanted joints, without the 
presence of infection, which is likely due to the pres-
ence of a foreign body. The implant-related inflammation 
Fig. 4 Quadratic discriminant analysis (QDA) revealed distinct groupings for primary TKA vs. TKR (aseptic or septic). Cytokines with significant 
infection-dependent or implant-related elevations via two-way ANOVA were analyzed via quadratic discriminant analysis. Canonical scores for each 
cytokine (covariate) were calculated, and the 95% confidence interval is shown for primary TKA (green), aseptic TKR (red), and septic TKR (blue). The 
+ symbol represents the mean of each group. Biplot rays describe the degree of association of a certain cytokine with canonical variables
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reflected less of the macrophage activation present in 
the septic TKR group, but exhibited elevation in anti-
inflammatory cytokines like IL-10, IL-4, and IL-13 fre-
quently associated with bone healing [7]. IL-17A and 
IL-12p70 have both pro- and anti-inflammatory roles, 
but the specific contributions to foreign body response 
are not well understood. Elevation of these cytokines, 
as well as TNF-α, implies there may be dysregulation of 
inflammatory response due to implant. These cytokines 
were not significantly elevated in infection at the p < 0.05 
level, so they may be considered as indicators of aseptic 
or chronic inflammation that could be addressed with 
future research associated with TKA. Further, QDA anal-
ysis illustrated that cytokine profiles are distinct between 
all three cohorts, but there is significant overlap in the 
95% confidence intervals of aseptic TKR and septic TKR. 
While there are several cytokines that distinctly separate 
these two cohorts, this analysis indicated that the degree 
of inflammation experienced between these groups is 
comparable. This finding agrees with the clinical decision 
to address inflammation and perform revision surgery, 
and these markers (IL-10, IL-12p70, IL-13, IL-17A, IL-4, 
and TNF-α) may show promise as helpful diagnostic 
monitoring markers for patients suffering from inflam-
matory complications in the absence of infection.
While this study had several limitations (i.e., single 
operating surgeon, heterogeneous cohort of patients, 
pathogen variability), it represents a novel characteriza-
tion of tissue-level cytokines across different anatomical 
locations in response to implants as well as infection-
specific inflammation. Further, these cytokines may give 
insight into the health of localized tissue following these 
procedures. Additionally, it highlights the utility of inves-
tigating a truly localized view of tissue health, by testing 
tissues surrounding the joint following these procedures; 
this approach could aid clinicians’ understanding of the 
localized tissue to better support clinical decision mak-
ing. At the time of publication, all patients had reached 
at least the 1-year post-operative follow up without need 
for revision, with no recurrent infections, and the predic-
tive value of these cytokines for successful surgical out-
comes is of interest in future studies. These cytokines 
could potentially be incorporated to intra-operatively 
assess the amount of inflammation during surgery, pro-
viding information in real time about the viability of tis-
sues for debridement. A more focused investigation of 
infection-specific markers IL-1α, IL-1β, IL-6, IL-8, MCP-
1, MIP-1α, and MIP-1β could provide insight into the 
power of these cytokines to discriminate aseptic vs. sep-
tic tissues.
Conclusions
In conclusion, this exploratory pilot study identified 
several cytokines that exhibited higher concentrations 
in response to implant-related and infection-specific 
post-operative inflammation. Some of these cytokines 
have been previously implicated in chronic inflamma-
tion and infection following TKA/TKR on a systemic 
level [11, 12, 30–33], and this study confirmed this 
trend on a localized tissue level. Literature has already 
illustrated that local inflammation is much more 
important for early post-operative recovery for a few 
markers [6], and this study expanded on that knowledge 
to provide an extended view of inflammatory cytokines 
Table 2 Pairwise pearson correlation values between cytokine concentrations and age, sex, and BMI
The pairwise correlation values are listed for each of the three groups: primary TKA, aseptic TKR, and septic TKR. Pearson correlation values are rounded to two decimal 
places. No correlations were found to be significant at the p < 0.05 level after Bonferroni’s correction
Cytokine Primary TKA Aseptic TKR Septic TKR
Age Sex BMI Age Sex BMI Age Sex BMI
IL-1α 0.00 0.47 0.28 0.20 0.22 − 0.54 − 0.15 0.25 − 0.05
IL-1β − 0.19 − 0.06 − 0.04 − 0.30 − 0.30 0.08 0.03 0.26 0.05
IL-6 0.00 − 0.09 − 0.12 0.03 − 0.19 − 0.21 0.00 0.22 − 0.02
IL-8 0.03 0.59 0.25 0.06 − 0.07 − 0.32 − 0.13 0.14 − 0.14
MCP-1 0.04 0.13 0.14 − 0.18 − 0.44 0.45 − 0.07 0.20 − 0.15
MIP-1α − 0.10 0.13 − 0.04 − 0.05 − 0.30 0.09 0.33 0.08 − 0.13
MIP-1β − 0.04 0.19 0.03 0.23 − 0.06 − 0.38 0.21 0.13 − 0.16
IL-10 − 0.26 0.29 0.17 − 0.31 0.00 − 0.20 − 0.11 − 0.25 0.30
IL-12p70 − 0.06 0.02 0.03 − 0.03 0.49 − 0.32 − 0.30 − 0.18 0.33
IL-13 − 0.19 0.49 0.28 − 0.06 0.41 − 0.06 − 0.22 − 0.23 0.22
IL-17A 0.00 − 0.08 − 0.31 0.31 0.85 − 0.45 − 0.34 0.06 0.32
IL-4 − 0.32 0.20 0.29 0.34 0.35 − 0.55 0.21 0.02 − 0.11
TNF-α − 0.22 0.34 0.25 0.45 0.72 − 0.38 − 0.45 − 0.12 0.25
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involved in tissue health. Future studies will build off 
this localized tissue-level information to investigate 
the mechanisms of dysregulation observed between the 
groups.
Overall, investigating the localized tissue-level 
cytokines to understand implant-related and infection-
specific inflammatory complications following knee 
arthroplasty may offer insight into localized response 
and provide new diagnostic and therapeutic options. 
Although this study did not control for age, sex, or BMI, 
these cytokines were not significantly correlated to these 
variables, suggesting these were not confounding factors 
(Table 2) in this study. Future work will focus on studies 
to include a larger cohort of patients to control for a vari-
ety of factors, including age, sex, BMI, and comorbidi-
ties. Ultimately, this study provided a basis to study these 
cytokines in surgical scenarios as a quantitative means 
to verify clinical decisions. More research is needed to 
confirm potential localized biomarkers that may be asso-
ciated with chronic inflammation. In the future, larger 
cohort studies could utilize the infection-specific bio-
markers for retrospective review of patient outcomes 
throughout the rehabilitation process.
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